Skip to main content

Lakeside Advisors, INC.

Position in NVO — Novo Nordisk A S

CIK 1913467 SEATTLE, WA

Position in NVO

as of Jun 30, 2026 · filed Jul 31, 2026
Position Value
$764,643
+$178,481 QoQ
Shares Held
15,950
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#584
of 1,348 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Lakeside Advisors, INC. holds $12,885,078 across 8 Drug Manufacturers - General names. NVO ranks #4 (5.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NVO
Novo Nordisk A S
This page
15,950 $764,643

All Filings in NVO

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $764,643 15,950
2026-03-31 $586,162 15,950
2025-12-31 $880,224 17,300
2025-09-30 $990,496 17,850
2025-06-30 $1,301,027 18,850
2025-03-31 $1,322,832 19,050
2024-12-31 $1,604,273 18,650
2024-09-30 $2,268,283 19,050
2024-06-30 $2,719,197 19,050
2024-03-31 $2,600,100 20,250
2023-12-31 $2,094,862 20,250
2023-09-30 $1,896,099 20,850
2023-06-30 $1,719,443 10,625
2023-03-31 $1,632,776 10,260
2022-12-31 $1,375,054 10,160
2022-09-30 $977,370 9,810
2022-06-30 $318,689 2,860
2022-03-31 $278,735 2,510
2021-12-31 $208,320 1,860